Positive EMA feedback on planned pivotal trial in septic shock Important step forward in global regulatory strategy for Adrecizumab Hennigsdorf/Berlin (Germany), December 2, 2021 – Adrenomed AG, the vascular integrity company, today announced that it
Adrenomed will be attending J.P. Morgan 40th Annual Healthcare Conference 2022! Join us for #HealthcarePartneringWeek! You are welcome to contact Dr. Frauke Hein, Chief Business Officer of Adrenomed, at BD@adrenomed.com to arrange a meeting, where
Andreas Bergman, CSO and Frauke Hein, CBO were interviewed by Maike Telgheder from Handelsblatt. Check out the article (German only) here: Link to Handelsblatt article
Hennigsdorf/Berlin (Germany), August 30th, 2021 – Adrenomed AG, the vascular integrity company, announced today its participation in four upcoming scientific and industry events. Adrenomed representatives will be available for networking and one-on-one meetings at the
Weimar Sepsis Update, Sep 8-10, 2021 Adrenomed will co-host the symposium “Precision Medicine in Septic Organ Failure: Biomarker-guided Diagnosis and Therapy” on September 9th, 12:00-13:30 CEST Chair: Prof. Dr. med. Markus Weigand Link to the
ISICEM, Aug 31 – Sep 3, 2021 Prof. Pierre-François Laterre, MD, Head of the medical-surgical intensive care unit at Saint Luc University Hospital, Brussels, will talk about Adrecizumab in the session “The Future of Sepsis
Solebury Trout Venrock’s 5th Annual EU Investor Tour 13-14 July, 2021 | Delivered Digitally Adrenomed will give a company presentation on July 13th at 11.15 pm ET / 5.15 pm CEST. Speaker: Dr. Jens Zimmermann,
For 2021, the BIO International Conference will be held as BIO Digital 10 – 18 June, 2021 | Delivered Digitally Adrenomed will be available for one-on-one meetings. Request a meeting via https://www.bio.org/events/bio-digital/partnering Link to the
Adrenomed was featured in the Deutsche Welle report “On the wave of BioNTech success – is it becoming easier to get financing for innovation?” Check out the video with Andreas Bergmann, CSO, and Frauke Hein,
By loading the map, you agree to Google's privacy policy.
Learn more
© 2024 AdrenoMed AG | Imprint/Impressum | Legal Notice/Datenschutzerklärung | Expanded Access Policy
